Pyrimidine sulfonylacetanilides with improved potency against key mutant viruses of HIV-1 by specific targeting of a highly conserved residue

Zheng-Yong Wan; Jin Yao; Tian-Qi Mao; Xin-Long Wang; Haifeng Wang; Wenxue Chen; Hong Yin; Fen‐Er Chen; De Clercq Erik; Dirk Daelemans; Christophe Pannecouque

doi:10.1016/j.ejmech.2015.08.007

Related publications

Article2024

Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIs

Yanying Sun, Zhenzhen Zhou, Na Wang, Fabao Zhao, Ying Liu, Xiaoxuan Xu, Xiaohan Wang, Zhenbang Gou, De Clercq Erik, Christophe Pannecouque, Peng Zhan, Dongwei Kang, Xinyong Liu

Article2011

Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly

Jörg Votteler, Liane Neumann, Sabine Hahn, Friedrich Hahn, Pia Rauch, Kerstin Schmidt, Nicole Studtrucker, Sara M. Ø. Solbak, Torgils Fossen, Peter Henklein, David E. Ott, Gudrun Holland, Norbert Bannert, Ulrich Sigmar Schubert

Article2020

Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase

Ya-Li Sang, Christophe Pannecouque, De Clercq Erik, Chunlin Zhuang, Fen‐Er Chen

Article2019

Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus

Zhongxia Zhou, Tao Liu, Gaochan Wu, Dongwei Kang, Zhipeng Fu, Zhao Wang, De Clercq Erik, Christophe Pannecouque, Peng Zhan, Xinyong Liu

Article2018

Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus

Ye Tian, Zhaoqiang Liu, Jinghan Liu, Boshi Huang, Dongwei Kang, H. Zhang, De Clercq Erik, Dirk Daelemans, Christophe Pannecouque, Kuo‐Hsiung Lee, Chin‐Ho Chen, Peng Zhan, Xinyong Liu